The effectiveness of brain stimulation depends on more than the stimulation itself. It also depends on where that stimulation is delivered.
Standard transcranial magnetic stimulation (TMS) therapy and fMRI-guided TMS therapy use the same non-invasive technology, but they approach treatment planning very differently.
A standard approach relies on fixed anatomical landmarks based on population averages, whereas an individualized approach uses each patient’s functional brain imaging and connectivity data to identify person‑specific treatment targets.
Understanding that distinction can help answer an important question: Why does precision matter?
At Neurotherapeutix, our approach begins with fMRI-guided TMS therapy, using functional connectivity data to guide individualized treatment planning.
As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, we believe understanding where stimulation is delivered is just as important as the stimulation itself.
What is standard TMS therapy and how does it work?
Standard TMS therapy has helped expand access to non-invasive brain stimulation and has become an established treatment option for several mental health conditions.
According to the National Institute of Mental Health, TMS therapy uses magnetic pulses to stimulate specific areas of the brain involved in mood, cognition, and emotional regulation. It is commonly used when symptoms have not adequately improved with first-line treatments.
Understanding how standard TMS therapy works provides an important foundation for understanding how fMRI-guided approaches differ.
The mechanism: magnetic pulses and cortical stimulation
TMS therapy uses a magnetic coil positioned against the scalp to generate focused magnetic pulses.
These pulses pass through the skull and influence activity within targeted brain circuits. Over time, repeated stimulation may help support neuroplasticity, the brain’s ability to strengthen and reorganize neural connections.
Patients remain awake during treatment and can typically return to normal daily activities afterward.
Understanding how TMS therapy works provides useful context for comparing standard and connectivity-guided approaches.
How targets are selected in standard protocols
Most standard TMS therapy protocols identify treatment targets using scalp measurements and generalized anatomical landmarks.
For example, clinicians may approximate a stimulation site in the dorsolateral prefrontal cortex using scalp measurements or established positioning formulas. These methods are widely used and supported by clinical research, but they rely on external head measurements and group‑average data rather than the patient’s own brain anatomy, so the actual stimulation site can be substantially off and may not even fall fully within the true dorsolateral prefrontal region.
In practice, this means a fixed anatomical spot on the scalp is treated as if it reliably corresponds to the intended cortical target, even though it does not guarantee that stimulation reaches the same brain region or functional network in every patient..
The challenge is that both brain structure and connectivity can differ from person to person, so a ‘standard’ scalp location can map to different underlying tissue and network organization across patients. This variability is one reason Neurotherapeutix focuses on fMRI‑guided, personalized targeting that is based on each patient’s own brain networks rather than generalized anatomical assumptions.
What FDA clearance for standard TMS therapy covers
FDA-cleared TMS therapy protocols have demonstrated effectiveness for several conditions and have helped expand access to non-invasive brain stimulation.
Today, repetitive transcranial magnetic stimulation (rTMS) is FDA-cleared for:
- Treatment-resistant depression
- Obsessive-compulsive disorder (OCD)
- Migraines
- Anxiety symptoms associated with depression
- Smoking dependence
However, TMS therapy does not produce the same therapeutic effects as electroconvulsive therapy (ECT), and it is not approved for children younger than 15 years old.
These clearances are based on standardized treatment approaches that have helped many patients.
The question is not whether standard TMS therapy works. It clearly can.
The question is whether a more individualized understanding of brain connectivity may help improve how treatment targets are selected.
What “fMRI-guided” means in practice
The term “fMRI-guided” refers to the use of functional magnetic resonance imaging (fMRI) to help determine where stimulation should be delivered.
Instead of relying solely on anatomical estimates, clinicians evaluate how brain networks communicate and use that information to guide treatment planning.
This is where Neurotherapeutix differs from traditional TMS providers.
Resting-state fMRI and functional connectivity mapping
At Neurotherapeutix, treatment begins with advanced imaging.
Resting-state functional MRI (rsfMRI) measures blood oxygen level-dependent (BOLD) signals while the brain is at rest. These signals help reveal how different brain regions communicate within larger functional networks.
Rather than simply identifying where structures are located, rsfMRI helps clinicians understand how neural systems interact.
This information serves as the foundation of our patented computational brain mapping process, which analyzes functional connectivity patterns across the brain to identify individualized treatment targets.
From imaging to individualized targeting coordinates
Once imaging data is collected, Neurotherapeutix’s patented computational brain mapping platform performs advanced analysis of connectivity patterns throughout the brain.
Clinicians can identify:
- Underactive networks
- Overactive networks
- Disrupted communication pathways
- Connectivity patterns associated with symptoms
This information helps determine individualized stimulation targets based on the patient’s own functional network architecture.
Rather than asking, “Where is the target usually located?” the question becomes, “Where is the target located in this particular brain?”
Why anatomical landmarks and functional networks don’t always match
Brain anatomy may look similar between individuals, but functional connectivity can vary significantly.
Research on connectivity-guided neuromodulation has shown that two patients with the same diagnosis may exhibit different network-level patterns that contribute to their symptoms.
This means that a generalized anatomical location may not always correspond to the same functional target from one person to the next.
The goal of fMRI-guided TMS therapy is to reduce that uncertainty by incorporating patient-specific network information into treatment planning.
Comparing the two approaches side by side
Both standard TMS therapy and fMRI-guided TMS therapy use magnetic stimulation. The primary difference lies in how treatment targets are selected.
| Category | Standard TMS Therapy | fMRI-Guided TMS Therapy |
|---|---|---|
| Targeting Method | Anatomical landmarks | Functional connectivity data |
| Imaging Used | Typically none | rsfMRI and computational analysis |
| Personalization | Standardized protocols | Individualized network mapping |
| Treatment Planning | Generalized positioning | Patient-specific targeting |
| Brain Network Analysis | Limited | Comprehensive connectivity evaluation |
| Monitoring | Clinical symptom tracking | Clinical tracking plus network-informed planning |
Targeting method: anatomical estimate vs. functional network data
Standard TMS therapy identifies targets based on generalized positioning techniques.
fMRI-guided TMS therapy uses each patient’s connectivity patterns to identify stimulation targets based on how their brain networks function.
Role of pre-treatment imaging
Most standard protocols do not require functional imaging before treatment.
At Neurotherapeutix, advanced imaging is the first step in the treatment process because it provides the data used for computational brain mapping and individualized treatment planning.
Understanding the differences between rsfMRI and SPECT imaging can help clarify why Neurotherapeutix relies on functional connectivity analysis when developing individualized treatment plans.
How treatment planning differs
Standard approaches focus on applying an established protocol.
fMRI-guided treatment planning begins with understanding the individual’s brain network architecture before determining where stimulation should be delivered.
Monitoring and adjustment during treatment
Both approaches involve ongoing clinical monitoring.
However, fMRI-guided treatment planning provides a more detailed understanding of the underlying network targets being addressed throughout care.
Why precision in targeting matters for outcomes
Brain stimulation is ultimately about influencing neural circuits.
The more accurately those circuits can be identified, the more precisely treatment can be directed.
Individual differences in brain network architecture
No two brains are wired the same way.
While patients may share diagnoses such as depression, anxiety, or OCD, the specific connectivity patterns contributing to symptoms can vary significantly.
This variation is one reason personalized treatment planning has become an area of increasing interest within neuroscience and psychiatry.
What happens when stimulation misses the intended circuit
If stimulation is delivered to a location that does not correspond to the intended functional network, treatment may still influence the brain, but not necessarily the circuit most closely associated with symptoms.
This does not mean standard TMS therapy is ineffective.
It means there may be value in understanding individual network architecture before selecting treatment targets.
How personalized targeting may improve the signal-to-noise ratio
One way to think about individualized targeting is through signal-to-noise ratio.
The goal is to maximize stimulation of the intended network while minimizing unnecessary variability.
By incorporating functional connectivity data into planning, clinicians can deliver stimulation with greater specificity and less reliance on generalized assumptions.
Who may benefit most from fMRI-guided TMS therapy?
Not every patient arrives at treatment for the same reason.
Some individuals are exploring TMS therapy for the first time. Others have already tried medications, psychotherapy, or even standard TMS therapy without achieving their desired results.
Those who haven’t responded to standard TMS therapy
Some patients seek evaluation after completing standard TMS therapy elsewhere.
In these situations, individualized connectivity analysis may provide additional information about treatment targets and network-level contributors to symptoms.
Complex presentations with overlapping conditions
Many patients experience more than one condition at the same time.
For example:
- Depression and anxiety
- PTSD and depression
- OCD and anxiety
- Cognitive symptoms alongside mood concerns
These overlapping presentations may involve multiple interacting networks rather than a single isolated circuit.
People who want a data-informed approach from the start
Some individuals simply prefer a more individualized approach from the beginning.
Rather than relying on generalized positioning methods, they want treatment planning informed by functional imaging and patient-specific connectivity data.
This is particularly common among individuals seeking treatment for depression who want a deeper understanding of how their symptoms may relate to underlying brain network activity before beginning therapy.
The case for knowing where you’re stimulating
The conversation about TMS therapy often centers on whether brain stimulation works.
A more useful question may be: How do you decide where stimulation should be delivered?
Standard TMS therapy and fMRI-guided TMS therapy share the same core technology. The difference is the amount of information used to guide treatment planning.
Our expert team believes understanding your brain’s unique connectivity patterns provides an opportunity to move beyond generalized targeting and toward individualized care.
As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, Neurotherapeutix combines functional imaging, connectivity analysis, and individualized targeting to create treatment plans based on how each patient’s brain networks actually function.
If you would like to discuss whether fMRI-guided TMS therapy may be appropriate for your needs, request an appointment with our team.
Frequently asked questions
Is fMRI-guided TMS therapy the same as standard TMS therapy?
No. While both approaches use magnetic stimulation to influence brain activity, the primary difference is how treatment targets are selected.
Standard TMS therapy typically relies on anatomical landmarks to approximate where to stimulate, while fMRI-guided TMS therapy incorporates each patient’s individual functional connectivity data and computational analysis into treatment planning.
Does fMRI guidance mean the treatment takes longer?
The TMS therapy sessions themselves are generally similar. However, fMRI-guided treatment includes additional imaging and computational analysis before treatment begins to support individualized planning.
Is MRI safe? Does it use radiation?
MRI does not use ionizing radiation. According to the National Institute of Biomedical Imaging and Bioengineering, MRI uses magnetic fields and radio waves to generate images and is considered a non-invasive imaging modality when appropriate screening guidelines are followed.
Does Neurotherapeutix accept insurance?
Neurotherapeutix is a private-pay practice. We do not submit claims, communicate with insurance companies, or manage reimbursement requests on behalf of patients. However, we provide visit documentation, clinical records, and billing information for patients who choose to pursue reimbursement independently.
How do I find out if I’m a candidate for fMRI-guided TMS therapy?
The first step is a consultation. During the evaluation process, clinicians review your symptoms, medical history, prior treatments, and treatment goals to determine whether fMRI-guided TMS therapy may be appropriate for your situation.
